ÂÜÀòÂÒÂ×

Tim Largen leads strategy and development of the company’s global cell manufacturing capabilities. He manages the internal manufacturing team, as well as relationships with external contract development and manufacturing organizations (CDMOs). Tim has over 20 years of experience helping companies move from clinical development into commercial production in cell and gene therapies and specialty sterile pharmaceuticals.

Tim joins Aurion Biotech from Lykan Bioscience, a start-up CDMO where he led manufacturing sciences and technologies supporting a diverse cell and gene therapy client base. Prior to Lykan, he spent nearly a decade in roles of increasing responsibility at Dendreon, where he was responsible for establishing and overseeing multiple high-volume cell therapy production processes, facilities, and CDMOs. In addition to Dendreon, Tim has held operations, supply chain, and quality leadership positions at several life sciences companies, including Caladrius Biosciences, Argos Therapeutics, Molecular Insight Pharmaceuticals, Inc., NeoRx, and others. Tim holds an M.B.A. in Operations Management Sciences and a B.S. in Biology from the University of North Texas.